Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RELISTOR
- Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
- Effects of Peripherally Acting ยต-opioid Receptor Antagonists on Acute Pancreatitis
- Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
- Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume
- Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
- Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
- Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients
- Methylnaltrexone Use for Opioid-induced Postoperative Constipation
- Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
- A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain
- Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
- Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
- Opioids and Esophageal Function
- Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
- Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?
- Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
- Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
- Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
Clinical trials list
click for details